U.S. Capital Wealth Advisors LLC Takes Position in Align Technology, Inc. (NASDAQ:ALGN)

U.S. Capital Wealth Advisors LLC acquired a new stake in Align Technology, Inc. (NASDAQ:ALGN - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 1,493 shares of the medical equipment provider's stock, valued at approximately $311,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Empirical Finance LLC lifted its holdings in shares of Align Technology by 2.1% during the 3rd quarter. Empirical Finance LLC now owns 2,486 shares of the medical equipment provider's stock valued at $632,000 after purchasing an additional 50 shares in the last quarter. Lake Street Advisors Group LLC raised its holdings in Align Technology by 5.6% during the 3rd quarter. Lake Street Advisors Group LLC now owns 1,042 shares of the medical equipment provider's stock worth $265,000 after buying an additional 55 shares during the period. Crestwood Advisors Group LLC lifted its stake in Align Technology by 6.6% in the third quarter. Crestwood Advisors Group LLC now owns 1,000 shares of the medical equipment provider's stock valued at $254,000 after buying an additional 62 shares in the last quarter. Mather Group LLC. boosted its holdings in shares of Align Technology by 51.6% in the third quarter. Mather Group LLC. now owns 185 shares of the medical equipment provider's stock valued at $47,000 after buying an additional 63 shares during the period. Finally, Beech Hill Advisors Inc. increased its position in shares of Align Technology by 0.6% during the fourth quarter. Beech Hill Advisors Inc. now owns 11,632 shares of the medical equipment provider's stock worth $2,425,000 after acquiring an additional 65 shares in the last quarter. 88.43% of the stock is currently owned by institutional investors and hedge funds.

Align Technology Stock Up 0.7 %

Shares of NASDAQ ALGN traded up $1.48 during trading hours on Monday, hitting $212.03. The company had a trading volume of 932,198 shares, compared to its average volume of 803,504. Align Technology, Inc. has a 1-year low of $196.09 and a 1-year high of $335.40. The firm's 50 day moving average is $221.25 and its 200-day moving average is $225.52. The stock has a market capitalization of $15.83 billion, a P/E ratio of 37.80, a price-to-earnings-growth ratio of 4.79 and a beta of 1.67.

Align Technology (NASDAQ:ALGN - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $1.96 EPS for the quarter, missing analysts' consensus estimates of $2.43 by ($0.47). Align Technology had a net margin of 10.54% and a return on equity of 13.84%. On average, sell-side analysts predict that Align Technology, Inc. will post 8.09 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on ALGN shares. Evercore ISI boosted their price objective on shares of Align Technology from $240.00 to $260.00 and gave the company an "outperform" rating in a research report on Thursday. Leerink Partners upgraded Align Technology from a "market perform" rating to an "outperform" rating and boosted their price target for the company from $235.00 to $280.00 in a report on Monday, January 6th. Robert W. Baird reduced their price objective on Align Technology from $325.00 to $276.00 and set an "outperform" rating for the company in a research report on Thursday, October 24th. Mizuho began coverage on Align Technology in a research report on Wednesday, December 4th. They issued an "outperform" rating and a $295.00 target price on the stock. Finally, Leerink Partnrs raised Align Technology from a "hold" rating to a "strong-buy" rating in a research report on Monday, January 6th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, Align Technology currently has an average rating of "Moderate Buy" and a consensus target price of $271.40.

About Align Technology

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.